oncolex logo
Utskriftsdato 7.7.2020

Referanser til intrakraniale svulster

  1. Helseth E et al. Intrakraniale svulster (517-538). Gjerstad L, Helseth E, Rootwelt T (Eds). Nevrologi og nevrokirurgi fra barn til voksen (5. utgave). Vett & Viten AS, Nesbru 2010.
  2. Kreftregisteret, Institutt for populasjonsbasert kreftforskning, Oslo, Norge
  3. Johannesen TB, Angell- Andersen E, Tretli S, Langmark F, Lote K. Trends in incidence of brain and central nervous system tumors in Norway 1970-1999. Neuroepidemiol 2004;23:101-109.
  4. Bhangoo SS et al. Evidence-based guidelines for the management of brain metastases. Neurosurg Clin N Am. 2011 jan;22(1):97-104, viii.
  5. Woodward ER, Wall K, Forsyth J, Macdonald F, Eamonn R. Maher ER. VHL mutation analysis in patients with isolated central nervous system heamangioblastoma. Brain 2007;130 (3):836-42.
  6. Louis DN et al. WHO classification of Tumoursof the Central Nervous System IARC Press Lyon 2007
  7. Hegi ME, DIserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M et al. MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma. N Engl J Med 2005;352:997-1003.
  8. Giannini C, Burger PC, Berkey BA, Cairncross JG, Jenkins RB, Mehta M et al. Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402. Brain Pathol. 2008:18 (3):360-369.
  9. Claus EB, Horlacher A, Hsu L, Schwartz RB, Dello-Iacono D, Talos F et al. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 2005;103:1227-33.
  10. Claus EB, Black PM. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas. Cancer 2006;106:1358-63.
  11. Stupp R, Mason W, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. NEJM 2005:352:987-96.
  12. Helseth R et al. Overall survival, prognostic factores, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme Acta Neurol Scand: 2010: 159-167
  13. Rogne S et al. Intracranial tumor surgery in patients > 70 years of age: is clinical practice worthwhile or futile? Actal Neurol Scand 2009: 120: 288-294
  14. Lassen B et al. Surgical Mortality at 30 Days and Complications Leading to Recraniotomy in 2630 Consecutive Craniotomies for Intracranial Tumors Neurosurgery 68: 1259-1269, 2011
  15. Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on servival in glioblastoma in a randomised phase III study: 5-years analysis of the EORTC-NCIC trial. Lancet oncol. 2009: 10; 459-466.
  16. Cancer in Norway 2018, Cancer Registry of Norway, Institute of Population-based Research. Oslo, Norway